State Key Laboratory of Cell Biology, Cas Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
School of Life Sciences, Xiamen University, Xiamen, Fujian Province, China.
Autophagy. 2022 Jun;18(6):1385-1400. doi: 10.1080/15548627.2021.1985338. Epub 2021 Oct 10.
Macrophages rapidly undergo glycolytic reprogramming in response to macroautophagy/autophagy, inflammasome activation and pyroptosis for the clearance of bacteria. Identification the key molecules involved in these three events will provide critical potential therapeutic applications. Upon infection, FLT4/VEGFR3 and its ligand VEGFC were inducibly expressed in macrophages, and FLT4 signaling inhibited CASP1 (caspase 1)-dependent inflammasome activation and pyroptosis but enhanced MAP1LC3/LC3 activation for elimination of the bacteria. Consistently, FLT4 mutants lacking the extracellular ligand-binding domain increased production of the proinflammatory metabolites such as succinate and lactate, and reduced antimicrobial metabolites including citrate and NAD(P)H in macrophages and liver upon infection. Mechanistically, FLT4 recruited AMP-activated protein kinase (AMPK) and phosphorylated Y247 and Y441/442 in the PRKAA/alpha subunit for AMPK activation. The AMPK agonist AICAR could rescue glycolytic reprogramming and inflammasome activation in macrophages expressing the mutant FLT4, which has potential translational application in patients carrying mutations to prevent recurrent infections. Collectively, we have elucidated that the FLT4-AMPK module in macrophages coordinates glycolytic reprogramming, autophagy, inflammasome activation and pyroptosis to eliminate invading bacteria. 3-MA: 3-methyladenine; AICAR: 5-aminoimidazole-4-carboxamide1-β-D-ribofuranoside; AMP: adenosine monophosphate; AMPK: AMP-activated protein kinase; ATP: adenosine triphosphate; BMDM: bone marrow-derived macrophage; CASP1: caspase 1; CFUs: colony-forming units; FLT4/VEGFR3: FMS-like tyrosine kinase 4; GFP: green fluorescent protein; LDH: lactate dehydrogenase; LPS: lipopolysaccharide; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; PEM: peritoneal exudate macrophage; PRKAA1/AMPKα1: protein kinase, AMP-activated, alpha 1 catalytic subunit; PYCARD/ASC: PYD and CARD domain containing; ROS: reactive oxygen species; SQSTM1/p62: sequestosome 1; TLR4: toll-like receptor 4; ULK1: unc-51 like autophagy activating kinase 1; VEGFC: vascular endothelial growth factor C; WT: wild type.
巨噬细胞在感应到大自噬/自噬、炎性小体激活和细胞焦亡时,会迅速经历糖酵解重编程,以清除细菌。鉴定参与这三个事件的关键分子将为潜在的治疗应用提供关键。在感染后,FLT4/VEGFR3 及其配体 VEGFC 在巨噬细胞中可诱导表达,FLT4 信号抑制了依赖 CASP1(半胱天冬酶 1)的炎性小体激活和细胞焦亡,但增强了 MAP1LC3/LC3 的激活,以消除细菌。一致地,缺乏细胞外配体结合域的 FLT4 突变体增加了促炎代谢物如琥珀酸和乳酸的产生,并减少了感染时巨噬细胞和肝脏中的抗菌代谢物,包括柠檬酸和 NAD(P)H。在机制上,FLT4 募集 AMP 激活的蛋白激酶(AMPK)并磷酸化 PRKAA/alpha 亚基的 Y247 和 Y441/442 以激活 AMPK。AMPK 激动剂 AICAR 可以挽救表达突变 FLT4 的巨噬细胞中的糖酵解重编程和炎性小体激活,这在预防携带突变的患者反复感染方面具有潜在的转化应用。总之,我们已经阐明,巨噬细胞中的 FLT4-AMPK 模块协调糖酵解重编程、自噬、炎性小体激活和细胞焦亡以消除入侵的细菌。3-MA:3-甲基腺嘌呤;AICAR:5-氨基咪唑-4-甲酰胺 1-β-D-核糖呋喃核苷;AMP:腺苷一磷酸;AMPK:AMP 激活的蛋白激酶;ATP:三磷酸腺苷;BMDM:骨髓衍生的巨噬细胞;CASP1:半胱天冬酶 1;CFUs:集落形成单位;FLT4/VEGFR3:FMS 样酪氨酸激酶 4;GFP:绿色荧光蛋白;LDH:乳酸脱氢酶;LPS:脂多糖;MAP1LC3/LC3:微管相关蛋白 1 轻链 3;PEM:腹腔渗出物巨噬细胞;PRKAA1/AMPKα1:蛋白激酶,AMP 激活,alpha 1 催化亚基;PYCARD/ASC:含 PYD 和 CARD 结构域;ROS:活性氧物种;SQSTM1/p62:自噬激活激酶 1 相关蛋白 1;TLR4: toll 样受体 4;ULK1:UNC-51 样自噬激活激酶 1;VEGFC:血管内皮生长因子 C;WT:野生型。